Characteristics and Glycemic Outcomes of T2D Patients (Pts) Titrated to 60 U/day with Insulin Glargine/Lixisenatide Fixed-Ratio Combination (iGlarLixi) vs. Insulin in the LixiLan-L Trial

被引：0
|
作者：
Blonde, Lawrence
Bailey, Timothy S.
Chao, Jason
Dex, Terry
Frias, Juan P.
Meneghini, Luigi F.
Roberts, Michelle
Aroda, Vanita R.
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1107-P
引用
收藏
页码：A294 / A294
页数：1
相关论文
共 50 条
  • [1] Characteristics and outcomes of type 2 diabetes patients titrated to 60U/day with insulin glargine/lixisenatide fixed-ratio combination vs insulin in LixiLan-L
    Blonde, L.
    Bailey, T. S.
    Chao, J.
    Dex, T.
    Frias, J. P.
    Meneghini, L. F.
    Roberts, M.
    Aroda, V. R.
    DIABETOLOGIA, 2017, 60 : S371 - S371
  • [2] Postprandial glycaemic outcomes of a fixed-ratio combination of insulin glargine and lixisenatide in the LixiLan-L trial
    Vidal, J.
    Giorgino, F.
    Stager, W.
    Nikonova, E. V.
    Vlajnic, A.
    Perfetti, R.
    Meier, J.
    DIABETOLOGIA, 2016, 59 : S382 - S383
  • [3] Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial
    Lawrence Blonde
    Timothy S. Bailey
    Jason Chao
    Terry A. Dex
    Juan Pablo Frias
    Luigi F. Meneghini
    Michelle Roberts
    Vanita R. Aroda
    Advances in Therapy, 2019, 36 : 2310 - 2326
  • [4] Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial
    Blonde, Lawrence
    Bailey, Timothy S.
    Chao, Jason
    Dex, Terry A.
    Frias, Juan Pablo
    Meneghini, Luigi F.
    Roberts, Michelle
    Aroda, Vanita R.
    ADVANCES IN THERAPY, 2019, 36 (09) : 2310 - 2326
  • [5] Outcomes of LixiLan, a fixed-ratio combination of insulin glargine/lixisenatide, versus insulin glargine and lixisenatide by baseline characteristics: LixiLan-O trial
    Guerci, B.
    Davies, M.
    Leiter, L. A.
    Grunberger, G.
    Ampudia-Blasco, F.
    Yu, C.
    Stager, W.
    Niemoeller, E.
    Souhami, E.
    Rosenstock, J.
    DIABETOLOGIA, 2016, 59 : S384 - S384
  • [6] Efficacy and safety of the insulin glargine/lixisenatide fixed-ratio combination versus insulin glargine in patients with T2DM: the LixiLan-L trial (NCT02058160).
    Aroda, Vanita
    Rosenstock, Julio
    Wysham, Carol
    Unger, Jeffrey
    Bellido, Diego
    Gonzalez-Galvez, Guillermo
    Guo, Hailing
    Takami, Akane
    Niemoeller, Elisabeth
    Souhami, Elisabeth
    Bergenstal, Richard
    PHARMACOTHERAPY, 2016, 36 (12): : E231 - E231
  • [7] Efficacy and safety of LixiLan, a fixed-ratio combination of insulin glargine plus lixisenatide in type 2 diabetes not adequately controlled on basal insulin: LixiLan-L trial
    Aroda, V. R.
    Rosenstock, J.
    Wysham, C.
    Unger, J.
    Bellido, D.
    Galvez, G. Gonzalez
    Takami, A.
    Guo, H.
    Niemoeller, E.
    Souhami, E.
    Bergenstal, R. M.
    DIABETOLOGIA, 2016, 59 : S2 - S3
  • [8] Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed-Ratio Combination in Elderly Patients with T2D
    Handelsman, Yehuda
    Chovanes, Christina
    Dex, Terry
    Giorgino, Francesco
    Skolnik, Neil
    Souhami, Elisabeth
    Stager, William
    Frias, Juan Pablo
    DIABETES, 2016, 65 : A246 - A246
  • [9] Efficacy and Safety across the Final Dose Ranges in Patients with T2DM Receiving Insulin Glargine/Lixisenatide Fixed-Ratio Combination in the LixiLan-L Trial
    Ritzel, Robert
    Vidal, Josep
    Aroda, Vanita R.
    Wu, Yujun
    Souhami, Elisabeth
    Niemoeller, Elisabeth
    Henry, Robert R.
    DIABETES, 2016, 65 : A266 - A267
  • [10] Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial
    Aroda, Vanita R.
    Rosenstock, Julio
    Wysham, Carol
    Unger, Jeffrey
    Bellido, Diego
    Gonzalez-Galvez, Guillermo
    Takami, Akane
    Guo, Hailing
    Niemoeller, Elisabeth
    Souhami, Elisabeth
    Bergenstal, Richard M.
    DIABETES CARE, 2016, 39 (11) : 1972 - 1980
12345